Industry's neglect of prescribing information for children

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 9, 2011, Pages 994-995

  Peterson, Bob ^a   Hébert, Paul C ^c   MacDonald, Noni ^c   Rosenfield, Daniel ^b   Stanbrook, Matthew B ^c   Flegel, Ken ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; CANADA; CHILD; CHILD CARE; CHILD SAFETY; DRUG INDUSTRY; DRUG INFORMATION; DRUG LABELING; DRUG RESEARCH; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HUMAN; MEDICATION ERROR; PRESCRIBING INFORMATION;

EID: 79958712675     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.110563     Document Type: Editorial

References (5)

1. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a metaanalysis of randomized controlled trials. JAMA 2007;297:1683-96.
2. Pediatric Research Equity Act, Pub. L. No. 108-155, 117 Stat. 1936 (2003). Available: www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/ DevelopmentResources/UCM049870.pdf (accessed 2011 Apr. 6).
3. Regulation (EC) no. 1901/2006 of the European Parliament and of the Council on Medicinal Products for Pediatric Use, and amending Regulation (EEC) No. 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No. 726/2004 (2006).
4. Life sciences gateway. Canadian pharmaceutical industry profile. Ottawa (ON): Industry Canada; 2010. Available: www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/ h-hn00021.html (accessed 2011 Apr. 6).
5. Better medicines for children. World Health Assembly; 2007 May 14-23; Geneva (CH): World Helath Organization; 2007. Available: www.who.int/gb/ebwha/ pdf-files/WHA60/A60-R20-en.pdf (accessed 2011 Apr. 7).